What was recalled
The U.S. Food and Drug Administration has issued a Class II recall involving specific diagnostic testing kits manufactured by Healthmark Industries Co., Inc. This action targets two primary product lines: the healthmark ProChek-W Protein Test designed specifically for use with robotic arms, and the ProChek-Semi Quantitative Protein Test, identified under Model Number PT-SQ-001. These items are specialized medical devices intended for clinical or laboratory settings to detect protein levels, but they have been flagged for a significant quality control failure that renders their results unreliable.
The scope of this recall is defined by precise model and lot identifiers, which are critical for determining whether a specific unit is affected. The recalled inventory includes the ProChek-W Protein Test for Robotic Arms and the ProChek-Semi Quantitative Protein Test (Model PT-SQ-001). The specific serial and lot numbers subject to this recall are 200035, 200036, 200037, 200038, 200039, 200040, and 30028. It is important to note that while the official recall documentation does not explicitly state the total number of individual units affected, the inclusion of these specific lot numbers indicates a targeted withdrawal of inventory produced during those particular manufacturing runs.
This recall was initiated on July 29, 2026, and reflects a global distribution pattern rather than a localized issue. The affected products were not confined to a single region but were distributed worldwide, with confirmed sales and presence in the United States nationwide, as well as in Canada, France, Hong Kong, and South Korea. The manufacturing facility associated with this recall is located in Michigan. Because these diagnostic tools are often used in critical healthcare environments, the wide geographic distribution underscores the importance of verifying lot numbers across international supply chains to ensure patient safety and data integrity.
The classification of this recall as a Class II event by the FDA suggests that use of the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. However, given that these are diagnostic tests, the primary concern lies in the potential for misdiagnosis due to inaccurate results rather than direct physical injury from the device itself. Healthcare providers and laboratories must carefully inspect their current stock against the listed lot numbers to prevent any compromised test kits from being used in patient care scenarios.
The hazard, explained
At the heart of this recall is a subtle but significant failure in the chemical integrity of the testing kits. Healthmark Industries Co., Inc. has identified that specific lots of the ProChek-W Protein Test for Robotic Arms and the ProChek-Semi Quantitative Protein Test (Model Number PT-SQ-001) were manufactured using an ingredient that had passed its expiration date. While it might seem like a minor administrative oversight, the use of expired reagents in diagnostic devices can fundamentally alter how the test interacts with the sample being analyzed. In medical and laboratory diagnostics, precision is not just a preference; it is the entire foundation of patient care and operational safety.
To understand why this matters, we need to look at what these tests are actually doing. These semi-quantitative protein tests are designed to detect the presence and approximate amount of protein in a sample. They rely on specific chemical reactions that occur when the reagents in the test kit meet the sample. When an ingredient is fresh, it reacts predictably, producing a color change or signal that accurately reflects the protein levels. However, chemicals degrade over time. As ingredients expire, their molecular structure can break down or become unstable. This degradation means the reagent may no longer react with the target protein in the way it was designed to do.
This instability creates two distinct and dangerous outcomes: false negatives and false positives. A false negative occurs when the test indicates that a sample is clear or safe, but there is actually a problem present. In the context of robotic arms used in medical or industrial settings, this could mean missing a critical contamination issue or a malfunctioning component that requires attention. If a technician relies on this test to verify the cleanliness or status of a robotic arm and receives a "clean" result due to the faulty reagent, they may proceed with operations that should have been halted for maintenance or sterilization. This silence from the device is particularly dangerous because it gives users a false sense of security.
Conversely, a false positive suggests a problem where none exists. If the degraded ingredient reacts spontaneously or erratically, the test might signal a high protein level or contamination when the robotic arm is actually functioning correctly. This can lead to unnecessary downtime, costly replacement of perfectly good parts, and confusion among staff who are trying to troubleshoot a non-existent issue. In both scenarios, the core failure is the loss of reliability. The user cannot trust the data provided by the device. When diagnostic tools fail to provide accurate information, decisions made based on that information become guesses rather than informed actions, potentially leading to equipment damage, operational errors, or in broader medical contexts, compromised patient outcomes.
The severity of this Class II recall lies in the unpredictability of the error. Users cannot simply look at the result and know it is wrong; they must assume the test has failed entirely. This is why the FDA classifies such defects as Class II, indicating that use of the product could cause temporary health problems or pose a slight threat of serious injury. The physical mechanism here is invisible to the naked eye—you cannot see an expired ingredient in a liquid—but its impact on the validity of the entire testing process is profound and immediate.
Who is most at risk
To understand who is truly at risk in this recall, we first need to look past the typical consumer of household goods and focus on the specific environment where these devices operate. The Healthmark ProChek-W Protein Test for Robotic Arms and the ProChek-Semi Quantitative Protein Test (Model PT-SQ-001) are not items you will find in a standard home medicine cabinet or kitchen drawer. These are specialized diagnostic tools designed for use within clinical, laboratory, or industrial settings that rely on robotic automation for high-throughput testing. Consequently, the primary group "at risk" here is not the general public, but rather healthcare professionals, laboratory technicians, and medical staff who handle these specific test kits as part of their daily workflow.
The core danger in this scenario stems from the nature of the defect: an expired ingredient that can lead to either false negative or false positive results. For a layperson, a wrong answer on a home pregnancy test is frustrating but rarely life-threatening. However, for medical professionals using these tests to monitor patient protein levels—a critical indicator of kidney function, nutritional status, and overall health—the stakes are significantly higher. When a test yields an inaccurate result due to the compromised ingredient, it does not just provide bad data; it actively misleads clinical judgment.
Patients are the ultimate beneficiaries of this safety analysis, even though they did not purchase or directly handle the faulty equipment. The individuals most vulnerable in this chain are those undergoing rigorous protein monitoring, such as patients with chronic kidney disease, those on specialized nutritional support, or individuals recovering from major surgeries where protein levels dictate recovery trajectories. If a laboratory technician uses a recalled ProChek-W test kit and receives a false negative result, it could falsely reassure a doctor that a patient’s protein levels are stable when they are actually declining. Conversely, a false positive might lead to unnecessary interventions, additional invasive testing, or the prescription of inappropriate treatments, all of which expose the patient to physical harm and emotional distress without clinical benefit.
Furthermore, because this recall involves distribution across the United States, Canada, France, Hong Kong, and South Korea, the risk extends beyond a single local clinic. Laboratory networks that operate across multiple states or international borders may have distributed these specific lots (200035 through 200040, and 30028) to various facilities. This means that any healthcare provider in these regions who relies on automated robotic arms for protein testing could potentially be using a compromised unit. The risk is particularly acute in high-volume settings where the speed of robotic processing might outpace manual verification steps, allowing an erroneous result to enter the patient’s medical record before the error is detected. Therefore, the "risk" here is systemic: it affects the integrity of diagnostic data for countless patients who trust that their lab results are accurate and reliable.
How to tell if you have the recalled item
Identifying whether your specific test kit is part of this recall requires careful attention to three distinct pieces of information printed on the packaging: the brand name, the exact model designation, and the lot number. Because Healthmark Industries Co., Inc. manufactures several different diagnostic tools, simply having a "Healthmark" product does not automatically mean it is included in this action. You must verify that you possess one of the two specific products named in the FDA notice: the healthmark ProChek-W Protein Test for Robotic Arms or the ProChek-Semi Quantitative Protein Test. If your kit has a different name, such as a glucose test or a different protein assay variant not listed above, it is likely not affected by this specific recall.
The most critical step in confirming eligibility is locating the lot number. The FDA recall applies exclusively to tests manufactured with an expired ingredient, which was limited to specific production batches. You need to check the packaging for one of the following seven lot numbers: 200035, 200036, 200037, 200038, 200039, 200040, or 30028. These numbers are typically printed on the side or bottom of the box, often near a barcode or expiration date. If your lot number does not match one of these seven exactly, your product is safe from this particular defect and does not need to be returned.
For the ProChek-Semi Quantitative Protein Test, you should also verify the model number. The recall specifically lists Model Number PT-SQ-001. While the notice does not provide details on packaging colors, sizes, or retail prices for these items, it is worth noting that these devices were distributed globally. This means they may have been purchased in the United States, Canada, France, Hong Kong, or South Korea. If you acquired this test kit through a medical supply distributor or a laboratory retailer in any of these regions, and the lot number matches one of the affected batches, you should treat it as recalled.
To be absolutely certain, compare your physical product against the details provided here. Look for the Healthmark branding, confirm the model is ProChek-W or PT-SQ-001, and double-check that the lot number is among the seven listed. If any part of this description does not match your item, you can rest easy knowing your test kit is not part of this recall. However, if all details align, please proceed to the next steps for safe disposal or return.
What to do — step by step
If you are a laboratory professional or a facility manager currently using the Healthmark ProChek-W Protein Test for Robotic Arms or the ProChek-Semi Quantitative Protein Test (Model Number PT-SQ-001), your immediate priority is to ensure that no further testing relies on these specific kits. The recall, initiated by the Food and Drug Administration on July 29, 2026, addresses a critical manufacturing error: the use of an expired ingredient. While the official remedy details regarding refunds, repairs, or replacements have not been explicitly stated in the initial FDA announcement, the fundamental safety protocol for any medical device recall involving potential diagnostic errors remains consistent and urgent. Your first concrete step is to physically locate all units associated with this recall within your facility. This requires a meticulous audit of your inventory systems, specifically looking for the lot numbers identified in the recall notice.
You must verify that you possess any of the following specific serial or lot numbers: 200035, 200036, 200037, 200038, 200039, 200040, and 30028. If you are unsure of your current stock levels, reach out to your procurement department or laboratory supply chain coordinator immediately. Do not rely on general product names alone; the model number PT-SQ-001 is essential, but the lot numbers are the definitive markers of the affected units. Once you have identified any kits matching these criteria, the second step is to strictly remove them from active use. Place these items in a secure, designated quarantine area within your laboratory or storage facility. It is vital that they are clearly labeled as "RECALLED" and physically separated from valid testing supplies to prevent accidental misuse by staff members who may not be aware of the recall status.
The third step involves halting any ongoing or scheduled tests that depend on these specific reagents. Because the expired ingredient can lead to false negative or false positive results, continuing to use these kits poses a significant risk to diagnostic accuracy. In a clinical or research setting, inaccurate protein test results can lead to incorrect patient diagnoses, flawed experimental data, or inappropriate treatment decisions. Therefore, you must pause any workflows dependent on the ProChek-W or ProChek-Semi Quantitative tests until alternative, non-recalled testing methods are implemented. Contact your laboratory information system administrator to flag these tests as unavailable in your electronic records if possible, ensuring that no automated orders or test requests are generated for these specific items.
The fourth step is to monitor official channels for further instructions from Healthmark Industries Co., Inc. and the FDA. Since the specific remedy—such as whether you will receive a prepaid return shipping label, a direct refund, or a replacement kit—has not yet been detailed in the public recall notice, you must wait for updated communications. Check the FDA’s official recall database regularly and contact Healthmark Industries directly using the customer service information provided in their initial recall press release. Document all your internal actions, including the date you removed the kits from use and the quantity of recalled units quarantined, as this documentation may be required when you eventually process your claim or replacement request.
Finally, communicate clearly with your team. Inform all laboratory staff, technicians, and supervisors about the recall to ensure everyone understands why these specific kits are out of service. Provide them with the lot numbers so they can visually inspect their workspaces. Clear communication prevents confusion and ensures that the safety protocols are followed uniformly across your entire operation. By taking these deliberate, step-by-step actions, you protect the integrity of your testing results and safeguard the individuals who rely on accurate medical or scientific data.
Your refund, repair, or replacement options
When a recall notice does not explicitly list a specific remedy, such as a direct refund, free repair service, or automatic replacement kit, it can feel unsettling and leave you wondering about your next steps. In this case, the FDA’s recall announcement for Healthmark Industries Co., Inc.’s ProChek-W Protein Test for Robotic Arms and the ProChek-Semi Quantitative Protein Test (Model Number PT-SQ-001) does not state a specific remedy. This absence of detailed instructions in the public summary is not unusual for Class II recalls, but it does mean that the path to resolution requires a bit more proactive engagement from you. You cannot assume that a check will be mailed or a new unit shipped automatically; instead, the onus is on the manufacturer and distributor to handle the logistics of the recall.
The first and most critical step in securing your options is to identify the specific lot numbers associated with your product. The recall involves lots 200035 through 200040, as well as lot 30028. If you possess any of these specific serial or lot numbers, you are holding a recalled item that contains an expired ingredient. Because the distribution pattern for this device includes the United States, Canada, France, Hong Kong, and South Korea, your contact point will depend on where you purchased the device. If you bought it directly from Healthmark Industries in the U.S., you should look for their official customer service or quality assurance contact information, which is typically found on the original packaging, the user manual, or their corporate website. Do not rely on third-party retailer support alone; the manufacturer holds the regulatory responsibility for the remedy.
Once you have located the correct contact information, reach out to Healthmark Industries directly. When you contact them, clearly state that you are initiating a recall claim for the ProChek-W or ProChek-Semi Quantitative Protein Test, providing your specific lot number and proof of purchase if available. Ask specifically what remedy they are offering for this Class II recall. Options may include a full refund of the purchase price, a credit toward future purchases, or a replacement unit manufactured with fresh, non-expired ingredients. It is important to get these terms in writing via email so you have a clear record of the agreement. Do not discard the recalled item until you have spoken with their recall coordinator, as they may need to inspect the physical product to verify the lot number and the nature of the defect.
If you are unable to locate Healthmark Industries’ direct contact details, or if they do not respond promptly, you should report your concern to the FDA’s MedWatch Safety Information and Adverse Event Reporting program. While the FDA does not process individual refunds, they can facilitate communication between you and the manufacturer and ensure that the company is complying with its recall obligations. This step also helps protect other users in the U.S. and abroad who may have received the same affected lots from Canada, France, Hong Kong, or South Korea. Remember, your safety is paramount, and while the remedy is not stated in the initial alert, a proper resolution should always be available through the manufacturer’s official channels.
What can happen if you ignore it
When a medical or laboratory diagnostic test is compromised by an expired ingredient, the immediate danger might seem abstract—a simple error on a strip or in a reagent bottle. However, in clinical and research settings, the consequences of ignoring this defect are far more tangible and potentially severe. The core issue with the recalled Healthmark ProChek-W Protein Test for Robotic Arms and the ProChek-Semi Quantitative Protein Test (Model Number PT-SQ-001) is that the expired ingredient can lead to results that are either falsely negative or falsely positive. This dual possibility creates a dangerous ambiguity that can disrupt critical decision-making processes in laboratories, hospitals, and research facilities worldwide.
If you continue to use these recalled units, the most significant risk lies in the potential for a false negative result. In protein testing, particularly when utilizing robotic arms for high-throughput analysis, a false negative implies that the test indicates the absence of a target protein when it is actually present. In a clinical diagnostic context, this could mean a patient’s condition goes undiagnosed or untreated. For example, if the test is used to monitor disease progression or treatment efficacy, a false negative might lead a healthcare provider to believe a therapy is working or that a symptom has resolved, when in reality, the underlying issue persists or worsens. This delay in accurate diagnosis can allow conditions to progress unchecked, potentially leading to more serious health outcomes that could have been mitigated with timely and accurate information.
Conversely, ignoring the recall also exposes users to the risk of a false positive result. A false positive indicates the presence of a protein when it is not actually there. This scenario can trigger unnecessary follow-up testing, invasive procedures, or even inappropriate treatments. Patients may undergo additional stress, financial burden, and physical discomfort due to tests that were prompted by erroneous data. In research environments, false positives can lead scientists down incorrect pathways, wasting valuable time, resources, and funding on hypotheses that are built on flawed data. This not only impacts individual patient care but can also hinder broader scientific progress and the reliability of published research.
Furthermore, because these tests are designed for use with robotic arms, the error is not isolated to a single manual reading. Robotic systems often process samples in batches or continuous workflows. A faulty test unit integrated into such a system could propagate incorrect data across multiple samples, amplifying the scope of the error. This systemic impact means that one ignored defect can potentially compromise an entire run of tests, affecting numerous patients or research subjects simultaneously. The integrity of laboratory data depends on the reliability of its components; using a device known to have manufacturing defects undermines this foundation and places everyone who relies on the resulting data at risk.
It is important to note that while the FDA recall notice does not currently list specific reported incidents or injuries, the potential for harm is inherent in the nature of the defect. Medical diagnostics are high-stakes tools where accuracy is paramount. By choosing to ignore the recall, you are essentially gambling with the accuracy of critical health information. The safest and most responsible course of action is to remove these units from service immediately and contact Healthmark Industries Co., Inc. for instructions on how to return or dispose of them properly. Protecting patient safety and data integrity should always be the priority.
Staying safe: broader tips
When it comes to medical and diagnostic devices, especially those used in laboratory or clinical settings, vigilance is your best line of defense. The recall we just discussed highlights a critical point: even reputable manufacturers can face issues with supply chains or ingredient sourcing. This serves as a reminder that safety isn't just about the device itself, but also about the integrity of its components. To stay safe, always verify the lot numbers and expiration dates on any diagnostic kit before you open it. If you notice any discrepancies or if the packaging looks tampered with, do not use the product. Instead, contact the manufacturer or your supplier immediately to report the issue. This simple step helps protect not only you but also others who might receive similar defective units.
Another important aspect of staying safe is understanding how these devices work and their limitations. For instance, protein tests like the ones recalled are designed to provide specific results under controlled conditions. Any deviation from the manufacturer's instructions can lead to inaccurate readings. False negatives or positives can have serious consequences, particularly in medical diagnostics where timely and accurate information is crucial. Therefore, it’s essential to follow the user manual carefully, ensuring that all steps are performed correctly. If you’re unsure about any part of the process, seek guidance from a healthcare professional or consult additional resources.
Regularly checking for product recalls can also help keep you informed and protected. The FDA and other regulatory bodies issue numerous recalls each year, covering everything from toys to medical devices. Subscribing to their notification services or regularly visiting their websites can ensure you’re up-to-date with the latest safety information. Additionally, consider setting up alerts on your smartphone or computer for specific product categories you’re interested in. This proactive approach can save you time and effort while keeping you informed about potential hazards.
Finally, fostering a culture of safety within your home or workplace is vital. Encourage open communication about any concerns or incidents related to products you use. Share this information with family members, colleagues, or anyone who might be affected. By working together, we can create a safer environment for everyone. Remember, prevention is always better than cure when it comes to health and safety.